Irritable bowel syndrome and migraine: Bystanders or partners?

Journal of Neurogastroenterology and Motility

Volumn 19, Issue 3, 2013, Pages 301-311

  Chang, Full Young ^a   Lu, Ching Liang ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Biopsychosocial model; Comorbidity; Irritable bowel syndrome; Migraine; Quality of life

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; BULKING AGENT; GABAPENTIN; LAXATIVE; MELATONIN; PROBIOTIC AGENT; SEROTONIN; SEROTONIN RECEPTOR; SPASMOLYTIC AGENT;

ACUPUNCTURE; ALLODYNIA; ALTERNATIVE MEDICINE; BEHAVIOR THERAPY; CEREBROVASCULAR ACCIDENT; CHILD ABUSE; CHRONIC FATIGUE SYNDROME; COMORBIDITY; DEPRESSION; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ECONOMIC ASPECT; FEEDBACK SYSTEM; FIBROMYALGIA; GENETIC POLYMORPHISM; HEALTH CARE COST; HEREDITY; HUMAN; HYPERSENSITIVITY; INSOMNIA; INTERSTITIAL CYSTITIS; IRRITABLE COLON; LIMB PAIN; MIGRAINE; PATHOGENESIS; PROGNOSIS; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; REVIEW; RISK FACTOR; SOCIAL ASPECT; SUICIDE ATTEMPT;

EID: 84880694603     PISSN: 20930879     EISSN: 20930887     Source Type: Journal    
DOI: 10.5056/jnm.2013.19.3.301     Document Type: Review

References (129)

1. Manchikanti L, Singh V, Datta S, Cohen SP, Hirsch JA; American Society of Interventional Pain Physicians. Comprehensive review of epidemiology, scope, and impact of spinal pain. Pain Physician 2009;12:E35-E70.
2. Azevedo LF, Costa-Pereira A, Mendonça L, Dias CC, Castro-Lopes JM. Epidemiology of chronic pain: a population-based nationwide study on its prevalence, characteristics and associated disability in Portugal. J Pain 2012;13:773-783.
3. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-1491.
4. Chang FY, Lu CL, Chen TS. The Current prevalence of irritable bowel syndrome in Asia. J Neurogastroenterol Motil 2010;16: 389-400.
5. Whitehead WE, Palsson OS, Levy RR, Feld AD, Turner M, Von Korff M. Comorbidity in irritable bowel syndrome. Am J Gastroenterol 2007;102:2767-2776.
6. Gwee KA, Wee S, Wong ML, Png DJ. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol 2004;99:924-931.
7. Lu CL, Chang FY, Lang HC, Chen CY, Luo JC, Lee SD. Gender difference on the symptoms, health seeking behavior, social impact and sleep quality in irritable bowel syndrome: a Rome II-based survey in an apparent healthy adult Chinese population in Taiwan. Aliment Pharmacol Ther 2005;21:1497-1505.
8. Mulak A, Paradowski L. [Migraine and irritable bowel syndrome.] Neurol Neurochir Pol 2005;39(4 suppl 1):S55-S60. [Polish]
9. Tietjen GE, Brandes JL, Peterlin BL, et al. Childhood maltreatment and migraine (part III). Association with comorbid pain conditions. Headache 2010;50:42-51.
10. Tietjen GE, Brandes JL, Peterlin BL, et al. Allodynia in migraine: association with comorbid pain conditions. Headache 2009;49: 1333-1344.
11. Warren JW, Howard FM, Cross RK, et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology 2009;73:52-57
12. Keller J, Chen YK, Lin HC. Association of bladder pain syndrome/ interstitial cystitis with urinary calculus: a nationwide population-based study. Int Urogynecol J 2013;24:565-571.
13. Watson WC, Sullivan SN, Corke M, Rush D. Globus and headache: common symptoms of the irritable bowel syndrome. Can Med Assoc J 1978;118:387-388.
14. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992;304:87-90.
15. Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther 2004;20:1195-1203.
16. Hershfield NB. Nongastrointestinal symptoms of irritable bowel syndrome: an office-based clinical survey. Can J Gastroenterol 2005;19:231-234.
17. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol 2006;6:26.
18. Chang FY, Lu CL. Irritable bowel syndrome in the 21st century: perspectives from Asia or Southeast Asia. J Gastroenterol Hepatol 2007;22:4-12.
19. Ford AC, Marwaha A, Lim A, Moayyedi P. Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol 2010;8: 401-409.
20. Chang L, Toner BB, Fukudo S, et al. Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 2006;130:1435-1446.
21. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40000 subjects. Aliment Pharmacol Ther 2003;17:643-650.
22. Gupta S, McCarson KE, Welch KM, Berman NE. Mechanisms of pain modulation by sex hormones in migraine. Headache 2011; 51:905-922.
23. Stark RJ, Ravishankar K, Siow HC, Lee KS, Pepperle R, Wang SJ. Chronic migraine and chronic daily headache in the Asia-Pacific region: a systematic review. Cephalalgia 2013;33:266-283.
24. Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia 2010;30:599-609.
25. Lipton RB. Chronic migraine, classification, differential diagnosis, and epidemiology. Headache 2011;51(suppl 2):77-83.
26. Chu CH, Liu CJ, Fuh JL, Shiao AS, Chen TJ, Wang SJ. Migraine is a risk factor for sudden sensorineural hearing loss: a nationwide population-based study. Cephalalgia 2013;33:80-86.
27. Yunus MB. Gender differences in fibromyalgia and other related syndromes. J Gend Specif Med 2002;5:42-47.
28. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140-1156.
29. Riedl A, Schmidtmann M, Stengel A, et al. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 2008;64:573-582.
30. MacLean EW, Palsson OS, Turner MJ, Whitehead WE. Development and validation of new disease-specific measures of somatization and comorbidity in IBS. J Psychosom Res 2012;73:351-355.
31. Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004;126:1665-1673.
32. Lu CL, Liu CC, Fuh JL, et al. Irritable bowel syndrome and negative appendectomy: a prospective multivariable investigation. Gut 2007;56:655-660.
33. Plesh O, Adams SH, Gansky SA. Self-reported comorbid pains in severe headaches or migraines in a US national sample. Headache 2012;52:946-956.
34. Chen YC, Tang CH, Ng K, Wang SJ. Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan. J Headache Pain 2012;13:311-319.
35. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.
36. Kumano H, Kaiya H, Yoshiuchi K, Yamanaka G, Sasaki T, Kuboki T. Comorbidity of irritable bowel syndrome, panic disorder and agoraphobia in a Japanese representative sample. Am J Gastroenterol 2004;99:370-376.
37. Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Aliment Pharmacol Ther 2004;190:1217-1224.
38. Guilera M, Balboa A, Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 2005;100:1174-1184.
39. Lee CT, Chuang TY, Lu CL, Chen CY, Chang FY, Lee SD. Abnormal vagal cholinergic function and psychological behaviors in irritable bowel syndrome patients with predominant bowel symptoms: a hospital-based Oriental Study. Dig Dis Sci 1998;43:1794-1799.
40. Whitehead WE, Bosmajian L, Zonderman AB, Costa PT Jr, Schuster MM. Symptoms of psychologic distress associated with irritable bowel syndrome, comparison of community and medical clinical samples. Gastroenterology 1988;95:709-714.
41. Balottin U, Poli PF, Termine C, Molteni S, Galli F. Psychopathological symptoms in child and adolescent migraine and tension-type headache: a meta-analysis. Cephalalgia 2013;33:112-122.
42. Suhr JA, Seng EK. Neuropsychological functioning in migraine: clinical and research implications. Cephalalgia 2012;32:39-54.
43. Camilleri M, Williams DE. Economic burden of irritable bowel syndrome, proposed strategies to control expenditure. Pharmacoeconomics 2000;17:331-338.
44. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer E. The impact of irritable bowel syndrome on health-related quality of life.Gastroenterology 2000;119:655-660.
45. Talley NJ, Zinsmeister AR, Melton LJ 3rd. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995;142:76-83.
46. Lu CL, Chen CY, Lang HC, et al. Current patterns of irritable bowel syndrome in Taiwan: the Rome II questionnaire on a Chinese population. Aliment Pharmachol Ther 2003;18:1159-1169.
47. Hu WH, Wong WM, Lam CL, et al. Anxiety but not depression determines health care-seeking behaviour in Chinese patients with dyspepsia and irritable bowel syndrome: a population-based study. Aliment Pharmacol Ther 2002;16:2081-2088.
48. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001;120:652-668.
49. Talley N, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet 2002;360:555-564.
50. Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome, a multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988; 95:701-708.
51. Lipton RB, Bigal ME. Migraine: epidemiology, impact, and risk factors for progression. Headache 2005;45(suppl 1):S3-S13.
52. Peng KP, Wang SJ. Migraine diagnosis: screening items, instruments, and scales. Acta Anaesthesiol Taiwan 2012;50:69-73.
53. Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 2002; 24:675-689; discussion 674.
54. Kozma CM, Barghout V, Slaton T, Frech F, Reeder CE. A comparison of office-based physician visits for irritable bowel syndrome and for migraine and asthma. Manag Care Interface 2002;15: 40-43, 49.
55. Cash B, Sullivan S, Barghout V. Total costs of IBS: employer and managed care perspective. Am J Manag Care 2005;11(1 suppl): S7-S16.
56. Giffin NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology 2003;60:935-940.
57. Kelman L. The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. Headache 2004;44:865-872.
58. Hansen JM, Lipton RB, Dodick DW, et al. Migraine headache is present in the aura phase: a prospective study. Neurology 2012;79: 2044-2049.
59. American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104(suppl 1):S1-S35.
60. Keszthelyi D, Troost FJ, Masclee AA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012;303:G141-G154.
61. Charles A. The evolution of a migraine attack-a review of recent evidence. Headache 2013;53:413-419.
62. Vecchia D, Pietrobon D. Migraine: a disorder of brain excitatory-inhibitory balance? Trends Neurosci 2012;35:507-520.
63. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. The International Classification of Headache Disorders revised criteria for chronic migraine-field testing in a headache specialty clinic. Cephalalgia 2007;27:230-234.
64. Manzoni GC, Bonavita V, Bussone G, et al. Chronic migraine classification: current knowledge and future perspectives. J Headache Pain 2011;12:585-592.
65. Case AM, Reid RL. Effects of the menstrual cycle on medical disorders. Arch Intern Med 1998;158:1405-1412.
66. Lund I, Lundeberg T. Is it all about sex? Acupuncture for the treatment of pain from a biological and gender perspective. Acupunct Med 2008;26:33-45.
67. Kröner-Herwig B, Gassmann J. Headache disorders in children and adolescents: their association with psychological, behavioral, and socio-environmental factors. Headache 2012;52:1387-1401.
68. Leonardi M, Raggi A, Bussone G, D'Amico D. Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center. Headache 2010;50: 1576-1586.
69. Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum 2007;36:339-356.
70. Barbas NR, Schuyler EA. Heredity, genes, and headache. Semin Neurol 2006;26:507-514.
71. Stam AH, Haan J, van den Maagdenberg AM, Ferrari MD, Terwindt GM. Migraine and genetic and acquired vasculopathies. Cephalalgia 2009;29:1006-1017.
72. Nielsen CS, Knudsen GP, Steingrímsdóttir ÓA. Twin studies of pain. Clin Genet 2012;82:331-340.
73. Saito YA, Talley NJ. Genetics of irritable bowel syndrome. Am J Gastroenterol 2008;103:2100-2104.
74. Camilleri M, Katzka DA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012;302:G1075-G1084.
75. Pizza V, Agresta A, Agresta A, et al. Migraine and genetic polymorphisms: an overview. Open Neurol J 2012;6:65-70.
76. Schürks M. Genetics of migraine in the age of genome-wide association studies. J Headache Pain 2012;13:1-9.
77. Burnett BB, Gardner A, Boles RG. Mitochondrial inheritance in depression, dysmotility and migraine? J Affect Disord 2005;88: 109-116.
78. Boles RG, Adams K, Li BU. Maternal inheritance in cyclic vomiting syndrome. Am J Med Genet A 2005;133A:71-77.
79. Kellow JE, Azpiroz F, Delvaux M, et al. Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology 2006;130:1412-1420.
80. Lee HF, Hsieh JC, Lu CL, et al. Enhanced affect/cognition-related brain responses during visceral placebo analgesia in irritable bowel syndrome patients. Pain 2012;153:1301-1310.
81. Kim HS, Rhee PL, Park J, et al. Gender-related differences in visceral perception in health and irritable bowel syndrome. J Gastroenterol Hepatol 2006;21:468-473.
82. Cady RK, Farmer K, Dexter JK, Hall J. The bowel and migraine: update on celiac disease and irritable bowel syndrome. Curr Pain Headache Rep 2012;16:278-286.
83. Baldacci F, Vedovello M, Ulivi M, et al. Triggers in allodynic and non-allodynic migraineurs. A clinic setting study. Headache 2013; 53:152-160.
84. Verne GN, Price DD, Callam CS, Zhang B, Peck J, Zhou Q. Viscerosomatic facilitation in a subset of IBS patients, an effect mediated by N-methyl-D-aspartate receptors. J Pain 2012;13:901-909.
85. Piché M, Arsenault M, Poitras P, Rainville P, Bouin M. Widespread hypersensitivity is related to altered pain inhibition processes in irritable bowel syndrome. Pain 2010;148:49-58.
86. Maizels M, Aurora S, Heinricher M. Beyond neurovascular: migraine as a dysfunctional neurolimbic pain network. Headache Published Online First: 3 Jul 2012. Doi: 10.1111/j.1526-4610. 2012.02209.x
87. Camilleri M, Di Lorenzo C. Brain-gut axis: from basic understanding to treatment of IBS and related disorders. J Pediatr Gastroenterol Nutr 2012;54:446-453.
88. Lesch KP, Waider J. Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron 2012;76:175-191.
89. Pytliak M, Vargová V, Mechírová V, Felšöci M. Serotonin receptors-from molecular biology to clinical applications. Physiol Res 2011;60:15-25.
90. Faerber L, Drechsler S, Ladenburger S, Gschaidmeier H, Fischer W. The neuronal 5-HT3 receptor network after 20 years of research--evolving concepts in management of pain and inflammation. Eur J Pharmacol 2007;560:1-8.
91. Lambru G, Matharu M. Serotonergic agents in the management of cluster headache. Curr Pain Headache Rep 2011;15:108-117.
92. Storr MA, Yüce B, Andrews CN, Sharkey KA. The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome. Neurogastroenterol Motil 2008;20:857-868.
93. Russo EB. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinol Lett 2008;29:192-200.
94. Juhasz G, Lazary J, Chase D, et al. Variations in the cannabinoid receptor 1 gene predispose to migraine. Neurosci Lett 2009;461:116-120
95. Beesley H, Rhodes J, Salmon P. Anger and childhood sexual abuse are independently associated with irritable bowel syndrome. Br J Health Psychol 2010;15(Pt 2):389-399.
96. Ringel Y, Drossman DA, Leserman JL, et al. Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. Gastroenterology 2008;134:396-404.
97. Tietjen GE, Peterlin BL. Childhood abuse and migraine: epidemiology, sex differences, and potential mechanisms. Headache 2011; 51:869-879.
98. Peterlin BL, Ward TN, Lidicker JR, Levin M. A retrospective, comparative study on the frequency of abuse in migraine and chronic daily headache. Headache 2007;47:397-401.
99. Romans S, Belaise C, Martin J, Morris E, Raffi A. Childhood abuse and later medical disorders in women. An epidemiological study. Psychother Psychosom 2002;71:141-150.
100. O'Connor OJ, McSweeney SE, McWilliams S, et al. Role of radiologic imaging in irritable bowel syndrome: evidence-based review. Radiology 2012;262:485-494.
101. Spiller RC. Neuropathology of IBS? Gastroenterology 2002;123: 2144-2147.
102. Palm-Meinders IH, Koppen H, Terwindt GM, et al. Structural brain changes in migraine. JAMA 2012;308:1889-1897.
103. Lakhan SE, Avramut M, Tepper SJ. Structural and functional neuroimaging in migraine: insights from 3 decades of research. Headache 2013;53:46-66.
104. Sas K, Párdutz A, Toldi J, Vécsei L. Dementia, stroke and migraine-some common pathological mechanisms. J Neurol Sci 2010;299: 55-65.
105. Lambert GA. The lack of peripheral pathology in migraine headache. Headache 2010;50:895-908.
106. Silberstein SD, Holland S, Freitag F, et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012;78:1337-1345.
107. Holland S, Silberstein SD, Freitag F, et al. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012;78:1346-1353.
108. Pitz M, Cheang M, Bernstein CN. Defining the predictors of the placebo response in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005;3:237-347.
109. Lu HC, Hsieh JC, Lu CL, et al. Neuronal correlates in the modulation of placebo analgesia in experimentally-induced esophageal pain: a 3T-fMRI study. Pain 2010;148:75-83.
110. de Craen AJ, Tijssen JG, de Gans J, Kleijnen J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. J Neurol 2000;247:183-188.
111. Duffy RA. Potential therapeutic targets for neurokinin-1 receptor antagonists. Expert Opin Emerg Drugs 2004;9:9-21.
112. Evans RW. A rational approach to the management of chronic migraine. Headache 2013;53:168-176.
113. Lee KJ, Kim JH, Cho SW. Gabapentin reduces rectal mechanosensitivy and increases compliance in patients with diarrhea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2005; 22:981-988.
114. Srinivasan V, Lauterbach EC, Ho KY, Acuña-Castroviejo D, Zakaria R, Brzezinski A. Melatonin in antinociception: its therapeutic applications. Curr Neuropharmacol 2012;10:167-178.
115. Lu WZ, Gwee KA, Moochhalla S, Ho KY. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2005;22:927-934.
116. Aydinlar EI, Dikmen PY, Tiftikci A, et al. IgG-based elimination diet in migraine plus irritable bowel syndrome. Headache 2013;53: 514-525.
117. Chang FY, Lu CL. Treatment of irritable bowel syndrome using complementary and alternative medicine. J Clin Med Assoc 2009; 72:294-300.
118. Manheimer E, Wieland LS, Cheng K, et al. Acupuncture for irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2012;107:835-847.
119. Adams J, Barbery G, Lui CW. Complementary and alternative medicine use for headache and migraine: a critical review of the literature. Headache 2013;53:459-473.
120. Guyuron B, Kriegler JS, Davis J, Amini SB. Five-year outcome of surgical treatment of migraine headaches. Plast Reconstr Surg 2011;127:603-608.
121. Lyseng-Williamson KA, Frampton JE. OnabotulinumtoxinA (BOTOX®): a guide to its use in preventing headaches in adults with chronic migraine. CNS Drugs 2012;26:717-723.
122. Aurora SK, Winner P, Freeman MC, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Headache 2011;51:1358-1373.
123. Malone MA. Irritable bowel syndrome. Prim Care 2011;38:433-447, vii.
124. Nørgaard M, Farkas DK, Pedersen L, et al. Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study. Br J Cancer 2011;104:1202-1206.
125. Breslau N, Schultz L, Lipton R, Peterson E, Welch KM. Migraine headaches and suicide attempt. Headache 2012;52:723-731.
126. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-434.
127. Sacco S, Ricci S, Carolei A. Migraine and vascular diseases: a review of the evidence and potential implications for management. Cephalalgia 2012;32:785-795.
128. Lewis DW. Migraine headaches in the adolescent. Adolesc Med 2002;13:413-432.
129. Montelli Tde C, Peraçoli MT, Rogatto SR, Kaneno R, do Prado CH, Rocha Pde M. Genetic and modifying factors that determine the risk of brain tumors. Cent Nerv Syst Agents Med Chem 2011;11:8-30.